Related Experiment Video
Updated: Jun 28, 2026
08:58
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
Genetic approaches for target identification in sleep/wake systems
Christopher J Winrow1, Fred W Turek, John J Renger
1Department of Depression and Circadian Disorders, Merck Research Laboratories, 770 Sumneytown Pike, West Point, PA 19486, USA. christopher_winrow@merck.com
Idrugs : the Investigational Drugs Journal
|November 7, 2008
Summary
Understanding sleep-wake balance is crucial for health, as imbalances link to cognitive issues and accidents. New research aims to find better treatments for sleep disorders by identifying novel genetic targets.
Area of Science:
- Neuroscience
- Genetics
- Sleep Medicine
Background:
- The health implications of sleep/wake imbalances are increasingly recognized.
- Current insomnia and sleepiness treatments have suboptimal risk:benefit ratios.
- Identifying novel therapeutic targets for sleep disorders is needed.
Purpose of the Study:
- To identify novel targets for improved therapeutic approaches in sleep/wake disorders.
- To advance the understanding of genetic influences on sleep/wake behaviors.
Main Methods:
- Combining refined phenotypic electroencephalographic (EEG) changes with chromosomal loci.
- Investigating genetic links to sleep/wake behaviors beyond overt observations.
Main Results:
- Recent research focuses on integrating detailed EEG phenotypes with genetic data.
- This approach aims to uncover novel genetic targets influencing sleep/wake regulation.
Conclusions:
- Novel targets for treating sleep/wake disorders can be identified through integrated genetic and EEG analyses.
- Improved therapeutic strategies for sleep disorders are possible with a deeper understanding of their genetic underpinnings.
Related Concept Videos
02:19Circadian Rhythms and Gene Regulation
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...